Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Autologous Transplantation Seems Less Efficacious in Poor Mobilizers with the Use of a Biosimilar of Filgrastim and Plerixafor: A Retrospective Comparative Analysis

INTRODUCTION: Biosimilars of granulocyte colony-stimulating factors (G-CSF) have shown similar efficacy to originator filgrastim (Neupogen® [NEU]; Amgen Inc.) as prophylaxis in neutropenia and in the mobilization of stem cells in patients receiving combination chemotherapy with G-CSF. METHODS: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Parody, Rocío, Sánchez-Ortega, Isabel, Ferrá, Christelle, Guardia, Ramon, Talarn, Carme, Encuentra, Maite, Fort, Eduard, López, David, Morgades, Mireia, Alonso, Eva, Ortega, Sandra, Sarrá, Josep, Gallardo, David, Ribera, Josep M., Sureda, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683658/
https://www.ncbi.nlm.nih.gov/pubmed/32700041
http://dx.doi.org/10.1007/s40487-020-00115-3

Ejemplares similares

Ejemplares similares